Gynecology and Obstetrics, Department of Surgical Sciences, City of Health and Science, University of Torino, Italy.
Adv Clin Exp Med. 2020 May;29(5):615-622. doi: 10.17219/acem/118849.
Endometriosis is a pseudoneoplastic disease that has a significant personal and social impact. Unlike other neoplastic diseases, its management is burdened by uncertainty and controversy. The aim of this article is to furnish clinicians with a simple, useful and updated tool to select an appropriate diagnostic-therapeutic care pathway for affected women. Guidelines and recommendations cite advances in diagnostics, novel medications and optimized assisted reproductive techniques; however, such advancements have not simplified the management of endometriosis, since they often lack an integrated, multidisciplinary view of diagnostic, therapeutic and reproductive scenarios that inevitably overlap in the management of the disease. We selected and compared major society guidelines on the diagnosis and treatment of endometriosis. Three international and 5 national guidelines were analyzed. The overlapping recommendations were extracted and mapped, developing a simplified diagnostic-therapeutic care pathway in the form of an algorithm. We subdivided the patient population attending our tertiary referral center according to 4 decision nodes: type (deep infiltrating endometriosis or isolated endometrioma); stage (I-IV according to the revised American Society for Reproductive Medicine classification); predominant health problem (pain or infertility); and fertility potential of the couple (normal/abnormal screening fertility). We identified 9 classes, each corresponding to a suggested mode of treatment (medical, surgical or assisted reproductive technique) according to the most recent evidence published. This simplified scheme is designed to standardize treatment and is intended for use as a tool in diagnostic and therapeutic planning with a view to reduce inappropriate treatment.
子宫内膜异位症是一种假肿瘤性疾病,对个人和社会都有重大影响。与其他肿瘤性疾病不同,其管理存在不确定性和争议。本文旨在为临床医生提供一种简单、有用和最新的工具,以选择适当的诊断-治疗方法来治疗受影响的女性。指南和建议引用了诊断、新型药物和优化的辅助生殖技术方面的进展;然而,这些进展并没有简化子宫内膜异位症的管理,因为它们通常缺乏对诊断、治疗和生殖方案的综合、多学科的观点,而这些方案在疾病的管理中不可避免地会重叠。我们选择并比较了子宫内膜异位症诊断和治疗的主要学会指南。分析了 3 项国际指南和 5 项国家指南。提取并映射了重叠的建议,制定了简化的诊断-治疗方法,以算法的形式呈现。我们根据 4 个决策节点将就诊于我们三级转诊中心的患者人群进行细分:类型(深部浸润性子宫内膜异位症或孤立的子宫内膜瘤);分期(根据修订后的美国生殖医学学会分类为 I-IV 期);主要健康问题(疼痛或不孕);和夫妇的生育潜能(正常/异常筛查生育力)。我们确定了 9 个类别,每个类别都根据最新发表的证据建议了一种治疗模式(药物、手术或辅助生殖技术)。这个简化的方案旨在标准化治疗,旨在作为诊断和治疗计划的工具,以减少不适当的治疗。